Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Seizures × Solutions × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Keratosis, Actinic 6 Neoplasms 5 Melanoma 3 Neoplasm Metastasis 2 Hematologic Neoplasms 2 Hemangioma 2 Warts 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors Harboring NTRK Fusion 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Pelvic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Nonmelanoma Skin Cancers 1 Mucositis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lung Neoplasms 1 Leukemia 1

Interventions

Levetiracetam 6 Cannabidiol 3 perampanel 2 Tranexamic Acid 2 ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Standard of Care 1 Spironolactone 1 Solutions 1 Sodium Chloride 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Pregabalin 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Magnesium Sulfate 1 Lurasidone Hydrochloride 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡